167 related articles for article (PubMed ID: 28704935)
1. Entrainment of Breast Cell Lines Results in Rhythmic Fluctuations of MicroRNAs.
Chacolla-Huaringa R; Moreno-Cuevas J; Trevino V; Scott SP
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28704935
[TBL] [Abstract][Full Text] [Related]
2. Identification of circadian-related gene expression profiles in entrained breast cancer cell lines.
Gutiérrez-Monreal MA; Treviño V; Moreno-Cuevas JE; Scott SP
Chronobiol Int; 2016; 33(4):392-405. PubMed ID: 27010605
[TBL] [Abstract][Full Text] [Related]
3. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
Wang B; Li J; Sun M; Sun L; Zhang X
IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the Dysregulation of miR-23b-3p, miR-195-5p, miR-656-5p, and miR-340-5p in Trastuzumab Resistance of HER2-Positive Breast Cancer Cells and System Biology Approach to Predict Their Targets Involved in Resistance.
Rezaei Z; Sebzari A; Kordi-Tamandani DM; Dastjerdi K
DNA Cell Biol; 2019 Feb; 38(2):184-192. PubMed ID: 30702337
[TBL] [Abstract][Full Text] [Related]
6. The investigation of miR-221-3p and PAK1 gene expressions in breast cancer cell lines.
Ergun S; Tayeb TS; Arslan A; Temiz E; Arman K; Safdar M; Dağlı H; Korkmaz M; Nacarkahya G; Kırkbeş S; Oztuzcu S
Gene; 2015 Jan; 555(2):377-81. PubMed ID: 25447917
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants and abnormal processing of pre-miR-182, a circadian clock modulator, in major depression patients with late insomnia.
Saus E; Soria V; Escaramís G; Vivarelli F; Crespo JM; Kagerbauer B; Menchón JM; Urretavizcaya M; Gratacòs M; Estivill X
Hum Mol Genet; 2010 Oct; 19(20):4017-25. PubMed ID: 20656788
[TBL] [Abstract][Full Text] [Related]
8. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
[TBL] [Abstract][Full Text] [Related]
9. miR-493-5p attenuates the invasiveness and tumorigenicity in human breast cancer by targeting FUT4.
Zhao L; Feng X; Song X; Zhou H; Zhao Y; Cheng L; Jia L
Oncol Rep; 2016 Aug; 36(2):1007-15. PubMed ID: 27375041
[TBL] [Abstract][Full Text] [Related]
10. Expression pattern of circadian rhythm-related genes and its potential relationship with miRNAs activity in endometrial cancer.
Hermyt E; Zmarzly N; Kruszniewska-Rajs C; Gola J; Jeda-Golonka A; Szczepanek K; Mazurek U; Witek A
Ginekol Pol; 2023; 94(1):33-40. PubMed ID: 36748323
[TBL] [Abstract][Full Text] [Related]
11. Analysis of serum genome-wide microRNAs for breast cancer detection.
Wu Q; Wang C; Lu Z; Guo L; Ge Q
Clin Chim Acta; 2012 Jul; 413(13-14):1058-65. PubMed ID: 22387599
[TBL] [Abstract][Full Text] [Related]
12. Suppressive role of miR-502-5p in breast cancer via downregulation of TRAF2.
Sun LL; Wang J; Zhao ZJ; Liu N; Wang AL; Ren HY; Yang F; Diao KX; Fu WN; Wan EH; Mi XY
Oncol Rep; 2014 May; 31(5):2085-92. PubMed ID: 24677135
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of miR-660-5p expression suppresses tumor development and metastasis in human breast cancer.
Shen Y; Ye YF; Ruan LW; Bao L; Wu MW; Zhou Y
Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252173
[TBL] [Abstract][Full Text] [Related]
14. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment.
Leung CM; Chen TW; Li SC; Ho MR; Hu LY; Liu WS; Wu TT; Hsu PC; Chang HT; Tsai KW
Oncol Rep; 2014 May; 31(5):2147-56. PubMed ID: 24626680
[TBL] [Abstract][Full Text] [Related]
16. Claudin 1 Expression Levels Affect miRNA Dynamics in Human Basal-Like Breast Cancer Cells.
Majer A; Blanchard AA; Medina S; Booth SA; Myal Y
DNA Cell Biol; 2016 Jul; 35(7):328-39. PubMed ID: 26982264
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-409-5p is upregulated in breast cancer and its downregulation inhibits cancer development through downstream target of RSU1.
Yu H; Xing H; Han W; Wang Y; Qi T; Song C; Xu Z; Li H; Huang Y
Tumour Biol; 2017 May; 39(5):1010428317701647. PubMed ID: 28459205
[TBL] [Abstract][Full Text] [Related]
18. Differences of time-dependent microRNA expressions in breast cancer cells.
Bozkurt SB; Ozturk B; Kocak N; Unlu A
Noncoding RNA Res; 2021 Mar; 6(1):15-22. PubMed ID: 33385103
[TBL] [Abstract][Full Text] [Related]
19. miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1.
Li H; Bian C; Liao L; Li J; Zhao RC
Breast Cancer Res Treat; 2011 Apr; 126(3):565-75. PubMed ID: 20505989
[TBL] [Abstract][Full Text] [Related]
20. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
